Introduction. Antibodies against Chlamydia pneumoniae are associated with the progression of abdominal aortic aneurysms (AAA), but cross-react with immunoglobulins in AAA walls indicating an autoimmune reaction. Report. Of 82 men with a small AAA followed for 1e5 years, 17% (10e27%) had antibodies against immunoglobulin, 3.7% had antinuclear antibodies (ANA), 19.5% (11e30%) had antinuclear core antibodies (ANCA), 2.4% had anti-beta-2-gpI IgG and 3,7% antibodies against cardiolipin.
Introduction
Recently, we published results showing that antibodies against Chlamydia pneumoniae outer membrane protein (OMP) purified from patients with abdominal aortic aneurysms (AAA) react with OMP, but we could not detect any sign of OMP in the wall of AAAs, but other proteins e possibly immunoglobulins e were cross-reacting with the anti-OMP antibody. 1 The correlation between antibodies against Cp and the progression of small AAA 2 strongly suggests a pathogenetic role of the protein that caused the antibodies to be produced. From the study, we cannot conclude that this protein was OMP, or that another protein with similar epitopes as OMP. The missing presence of OMP suggests another protein to be involved. The demonstrated potential cross-reaction with immunoglobulins could indicate an autoimmune reaction.
Consequently, we have analyzed serum samples from our cohort of screen detected AAA for antibodies against immunoglobulin and other known autoantibodies in order to study the frequency of autoantibodies in AAA and their correlation with the expansion rate of AAA. 3
Report
Serum from 82 men with a small AAA 2 were controlled annually for up till 5 years for expansion, and their baseline serum samples were tested for various known autoantibodies at the only laboratory in Denmark performing the tests routinely.
The median max. initial AAA-diameter: 32 mm. Median follow up time was 4.11 years, and median expansion rate was 2.44 mm/year. The interobserver variation of the diameter measurements was 1.4 mm. 4 The results are summarised in Table 1 ; the frequencies of autoantibodies were limited; 17% (95% C.I.: 10e27%) had IgM and/or IgG antibodies against *Corresponding author. Dr. J.S. Lindholt, PhD, Vascular Reserach Unit, Viborg Hospital, Postbox 130, 8800 Viborg, Denmark. E-mail address: Jes.S.Lindholt@Sygehusviborg.dk immunoglobulin, 3.7% (0.8e10.3%) had antinuclear antibodies (ANA), 19.5% (11e30%) had antinuclear core antibodies (ANCA), 2.4% (0.3e8.5%) had antibeta-2-gpI IgG and 3,7% (0.8e10.3%) had IgM and/or IgG antibodies against cardiolipin.
The presence of antibodies against immunoglobulin and ANCA were not correlated with aneurysmal progression rate; 2.67 and 3.01 mm/year, respectively, compared to 2.40 (P ¼ 0.68) and 2.45 (P ¼ 0.49) mm/ year annually among those without such antibodies.
Discussion
Known autoantibodies, including antibodies against immunoglobulin, are seldomly present in AAA and seem not to influence the progression of AAA. 
